We are live on
!
Find out more
VCG
Vantage Consulting Group Portfolio holdings
AUM
$19.7M
1-Year Est. Return
280.87%
This Fund
S&P 500
This Quarter
Est. Return
+17.65%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$1.23B
AUM Growth
–
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
86.51%
Top 10 Holdings %
Top 10 Hldgs %
94.5%
Holding
1,884
New
1,883
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$911M |
| 2 |
ADC Therapeutics
ADCT
|
+$55.1M |
| 3 |
KYNB
Kyntra Bio
KYNB
|
+$25.5M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$5.96M |
| 5 |
Kroger
KR
|
+$366K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.04% |
| 2 | Technology | 0.89% |
| 3 | Consumer Discretionary | 0.79% |
| 4 | Industrials | 0.61% |
| 5 | Consumer Staples | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Paylocity
PCTY
$7.38B
| $7K | ﹤0.01% |
+33
| New | +$6.35K |
|
1377
Qualys
QLYS
$5.1B
| $7K | ﹤0.01% |
+61
| New | +$6.03K |
|
1378
Ryder
R
$9.83B
| $7K | ﹤0.01% |
+120
| New | +$6.68K |
|
1379
RPC Inc
RES
$1.24B
| $7K | ﹤0.01% |
+2,275
| New | +$6.84K |
|
1380
RLI Corp
RLI
$5.62B
| $7K | ﹤0.01% |
+128
| New | +$6.13K |
|
1381
Saic
SAIC
$4.95B
| $7K | ﹤0.01% |
+77
| New | +$6.77K |
|
1382
Selective Insurance
SIGI
$5.65B
| $7K | ﹤0.01% |
+99
| New | +$5.93K |
|
1383
Sony
SONY
$137B
| $7K | ﹤0.01% |
+335
| New | +$5.83K |
|
1384
Spire
SR
$4.72B
| $7K | ﹤0.01% |
+111
| New | +$6.77K |
|
1385
Southwest Gas
SWX
$6.47B
| $7K | ﹤0.01% |
+118
| New | +$7.77K |
|
1386
Teradata
TDC
$2.92B
| $7K | ﹤0.01% |
+292
| New | +$6.26K |
|
1387
Trex
TREX
$4.51B
| $7K | ﹤0.01% |
+88
| New | +$6.73K |
|
1388
Visteon
VC
$2.79B
| $7K | ﹤0.01% |
+59
| New | +$6.22K |
|
1389
Vistra
VST
$50B
| $7K | ﹤0.01% |
+371
| New | +$6.91K |
|
1390
WD-40
WDFC
$3.05B
| $7K | ﹤0.01% |
+28
| New | +$6.78K |
|
1391
Werner Enterprises
WERN
$2.24B
| $7K | ﹤0.01% |
+184
| New | +$7.49K |
|
1392
WIX.com
WIX
$2.3B
| $7K | ﹤0.01% |
+27
| New | +$7.11K |
|
|
DAY
1393
DELISTED
Dayforce
DAY
| $7K | ﹤0.01% |
+66
| New | +$6.24K |
|
|
GCP
1394
DELISTED
GCP Applied Technologies Inc.
GCP
| $7K | ﹤0.01% |
+281
| New | +$6.53K |
|
|
SAFM
1395
DELISTED
Sanderson Farms Inc
SAFM
| $7K | ﹤0.01% |
+50
| New | +$6.59K |
|
|
RAVN
1396
DELISTED
Raven Industries Inc
RAVN
| $7K | ﹤0.01% |
+220
| New | +$5.79K |
|
|
PRSP
1397
DELISTED
Perspecta Inc. Common Stock
PRSP
| $7K | ﹤0.01% |
+281
| New | +$6.03K |
|
|
WPX
1398
DELISTED
WPX Energy, Inc.
WPX
| $7K | ﹤0.01% |
+806
| New | +$5.12K |
|
1399
Ashland
ASH
$3.33B
| $6K | ﹤0.01% |
+73
| New | +$5.52K |
|
1400
American Vanguard Corp
AVD
$68.4M
| $6K | ﹤0.01% |
+405
| New | +$5.97K |
|
Similar funds
MVG
NCM
FFGIM
PIM
HFG
SWM
ICM
SM
Vantage Consulting Group's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Vantage Consulting Group, which disclosed 1,884 positions worth $1.23B. Its ten largest holdings account for 94% of the portfolio.
Its largest position is Royalty Pharma: 21,477,282 shares worth $1.07B.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, followed by Technology and Consumer Discretionary.
- Vantage Consulting Group's largest Q4 2020 buy was Royalty Pharma: 21,477,282 shares worth $1.07B.
- Vantage Consulting Group's ten largest holdings make up 94% of its $1.23B portfolio in Q4 2020.
- Vantage Consulting Group disclosed 1,884 positions in Q4 2020, its first 13F filing on record.
Based on Vantage Consulting Group's 13F filing for Q4 2020, filed 12 Feb 2021.